Stock Region Penny Picks
Stock Region Penny Picks Watchlist Newsletter - Thursday, March 20, 2025.
Stock Region Penny Picks Watchlist Newsletter - Thursday, March 20, 2025
The stocks featured in this report were previously delivered in our trading room in real-time. To access Stock Region’s real-time trade ideas, then be sure to purchase a membership now.
Disclaimer: This newsletter is for informational purposes only and does not constitute financial advice. Please consult with a qualified financial advisor before making any investment decisions.
$LASE
Laser Photonics is making strategic moves in the robotics industry. The company has expanded its footprint by securing an order for its Glaze Tool, positioning itself as a key player in this rapidly evolving sector.
$EONR
EON Resources Inc. has upgraded its Enstream Capital Funding Letter of Intent to a total of $52.8 million. Here’s the breakdown of funds:
$22 million allocated for a seller agreement
$21 million dedicated to senior debt pay-off
$9.8 million targeted for field development
$WINT
Windtree is entering new territory with a license and supply agreement. The deal establishes Windtree as a sourcing partner for a small biotech company that has an FDA-approved product.
$BCTX
A positive update for BriaCell! A second Data Safety Monitoring Board has recommended continuing Phase 3 trials for its metastatic breast cancer treatment.
$EYEN
Eyenovia has taken a significant step by entering a non-binding Letter of Intent for a reverse merger with Betaliq. The proposed merger has sparked interest and speculation among investors.
$PSTV
Plus Therapeutics is making headlines with the introduction of REYOBIQ™, the FDA-accepted proprietary name for its lead drug candidate. This branding milestone adds momentum to the company's ongoing developments.
$ALUR
Allurion has shared initial results combining its Allurion Program with low-dose GLP-1 therapy. The goal? To optimize muscle mass and improve adherence to GLP-1 treatments, marking an innovative approach with significant potential.
$LAZR
Luminar Technologies ($LAZR) surpasses expectations despite reporting quarterly losses of $(1.26) per share. This figure beat the analyst estimate of $(2.54), showing a 50.39% improvement. Quarterly sales hit $22.48 million, 26.90% above the consensus estimate and a modest 1.67% growth compared to last year. A positive snapshot for investors keeping an eye on this company.
Disclaimer: Stock Region is not responsible for any losses incurred as a result of investments made based on the information in this newsletter. All investment decisions should be made at your own risk.
We are working endlessly to provide free insights on the stock market every day, and greatly appreciate those who are paid members supporting the development of the Stock Region mobile application. Stock Region offers daily stock and option signals, watchlists, earnings reports, technical and fundamental analysis reports, virtual meetings, learning opportunities, analyst upgrades and downgrades, catalyst reports, in-person events, and access to our private network of investors for paid members as an addition to being an early investor in Stock Region. We recommend all readers to urgently activate their membership before reaching full member capacity (500) to be eligible for the upcoming revenue distribution program. Memberships now available at https://stockregion.net